These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 2074088

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Why is management of patients with classical congenital adrenal hyperplasia more difficult at puberty?
    Charmandari E, Brook CG, Hindmarsh PC.
    Arch Dis Child; 2002 Apr; 86(4):266-9. PubMed ID: 11919101
    [Abstract] [Full Text] [Related]

  • 23. Adrenarche and puberty in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM, Öhl L, Rauh M, Schöfl C, Dörr HG.
    Horm Res Paediatr; 2011 Apr; 76(6):400-10. PubMed ID: 22123283
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Scalp hair 17-hydroxyprogesterone and androstenedione as a long-term therapy monitoring tool in congenital adrenal hyperplasia.
    Noppe G, de Rijke YB, Koper JW, van Rossum EF, van den Akker EL.
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):522-7. PubMed ID: 27061431
    [Abstract] [Full Text] [Related]

  • 27. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
    Quintos JB, Vogiatzi MG, Harbison MD, New MI.
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576
    [Abstract] [Full Text] [Related]

  • 28. Congenital adrenal hyperplasia: lessons from a multinational study.
    Frisch H, Waldhauser F, Lebl J, Solyom J, Hargitai G, Kovacs J, Pribilincova Z, Krzisnik C, Battelino T, MEWPE-CAH Study Group.
    Horm Res; 2002 Apr; 57 Suppl 2():95-101. PubMed ID: 12065936
    [Abstract] [Full Text] [Related]

  • 29. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.
    Falhammar H, Filipsson Nyström H, Wedell A, Brismar K, Thorén M.
    Eur J Endocrinol; 2013 Mar; 168(3):331-41. PubMed ID: 23211577
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Plasma androgens in congenital adrenal hyperplasia: androstenedione concentration as an index of adrenal androgen suppression.
    Keenan BS, McNeel R, Barrett GN, Holcombe JH, Kirkland RT, Clayton GW.
    J Lab Clin Med; 1979 Nov; 94(5):799-808. PubMed ID: 159330
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].
    Sulcová J, Lisá L, Dvorák P, Hampl R, Stárka L.
    Cesk Pediatr; 1990 Jun; 45(6):353-6. PubMed ID: 2289256
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Claahsen-van der Grinten HL, Sweep FC, Blickman JG, Hermus AR, Otten BJ.
    Eur J Endocrinol; 2007 Sep; 157(3):339-44. PubMed ID: 17766717
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency.
    Levine LS, Dupont B, Lorenzen F, Pang S, Pollack M, Oberfield SE, Kohn B, Lerner A, Cacciari E, Mantero F, Cassio A, Scaroni C, Chiumello G, Rondanini GF, Gargantini L, Giovannelli G, Virdis R, Bartolotta E, Migliori C, Pintor C, Tato L, Barboni F, New MI.
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1193-8. PubMed ID: 6271801
    [Abstract] [Full Text] [Related]

  • 38. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].
    Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Małunowicz EM, Grzechocińska B, Kamiński P, Bablok L, Przedlacki J, Bar-Andziak E.
    Endokrynol Pol; 2010 Dec; 61 Suppl 1():7-21. PubMed ID: 22127631
    [Abstract] [Full Text] [Related]

  • 39. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
    Gasparini N, Di Maio S, Salerno M, Argenziano A, Franzese A, Tenore A.
    Horm Res; 1997 Dec; 47(1):17-22. PubMed ID: 9010713
    [Abstract] [Full Text] [Related]

  • 40. Influence of hormonal control on LH pulsatility and secretion in women with classical congenital adrenal hyperplasia.
    Bachelot A, Chakhtoura Z, Plu-Bureau G, Coudert M, Coussieu C, Badachi Y, Dulon J, Charbit B, Touraine P, CAHLH study group.
    Eur J Endocrinol; 2012 Oct; 167(4):499-505. PubMed ID: 22893695
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.